Andere Sprachen Akero Therapeutics, Inc.

Aktien

A2PLNP

US00973Y1082

AKRO

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 18.04.2024			% 5 Tage	% 1. Jan.
20.51 ^USD	-5.05%		-6.09%	-12.16%

07.03.	Akero Therapeutics, Inc. gibt die Veröffentlichung der Ergebnisse der Phase 2b SYMMETRY Kohorte D Studie in Clinical Gastroenterology and Hepatology bekannt	CI
07.03.	Akero Therapeutics Insider verkaufte Aktien im Wert von $732.727, laut einer aktuellen SEC Einreichung	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Akero Therapeutics, Inc. - AKRO	05.04.
Ademi LLP Investigates Claims of Securities Fraud against Akero Therapeutics, Inc.	03.04.
Akero Therapeutics Raises $367 Million From Share Offering	08.03.
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares	08.03.
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares	08.03.
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology	07.03.
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology	07.03.
Akero Therapeutics, Inc. Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology	07.03.
Akero Therapeutics Insider Sold Shares Worth $732,727, According to a Recent SEC Filing	07.03.
Akero Therapeutics Insider Sold Shares Worth $2,465,063, According to a Recent SEC Filing	07.03.
Akero Therapeutics Announces Pricing of Public Offering of Common Stock	06.03.
Health Care Down on Growth Doubts -- Health Care Roundup	04.03.
Akero Therapeutics Proposes $300 Million Common Stock Offering -- Stock Down After Hours	04.03.
Akero Therapeutics Announces Proposed Public Offering of Common Stock	04.03.
Sector Update: Health Care Stocks Lean Lower Pre-Bell Monday	04.03.
Sector Update: Health Care	04.03.
US Equity Futures Turn Cautiously Lower Pre-Bell as Investors Eye Powell Testimony	04.03.
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell as Traders Hope for Clues to Timing of Rate Cuts	04.03.
Top Premarket Gainers	04.03.
Akero Therapeutics Reports Greater Fibrosis Improvement in Efruxifermin Phase 2b Study; Shares Gain Pre-Bell	04.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

We are working hard...

We are working hard to come back as soon as possible.
Nous travaillons dur pour revenir au plus vite.
Wir arbeiten hart daran, so schnell wie möglich zurückzukommen
Estamos trabajando duro para volver lo antes posible.
Stiamo lavorando sodo per tornare il prima possibile.
Wij werken hard om zo snel mogelijk weer terug te zijn.